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Currently, the community pharmacy industry is experiencing conditions of extreme 
hypercompetition. A hypercompetitive market is characterised by extremely intense rivalry 
amongst competitors with escalating and increasingly aggressive moves and counter-moves 
(D'Aveni, 1994, D'Aveni et al., 2010, Hitt et al., 2011).  In the pharmacy industry this 
condition of increasing competitiveness is based on price-quality positioning. Due to this 
increasing competitiveness, the pharmacy industry (along with many other markets and 
industries) has fallen prey to a particularly virulent type of hypercompetition – the 
commodity trap. With the emergence of the discount pharmacies and their growing 
dominance of the market, many traditional community pharmacies have found that they do 
not have the economies of scale to compete with the discount pharmacies on price and 
customers are becoming less and less willing to pay for additional benefits such as service 
and professional advice and expertise. As a consequence, these pharmacies are 
experiencing falling margins and loss of market share despite lowering prices to try and 
match competition.  
 
D’Aveni (2010a) refers to the commodity trap as “the modern corporate equivalent of the 
mediaeval black plague” since nearly every industry is experiencing it. Commoditization is 
defined as, “to render (a good or service) widely available and interchangeable with one 
provided by another company” (Merriam-Webster, 2013) and occurs when firms are driven 
“to constantly improve quality or other product benefits whilst decreasing prices to keep up 
with competitors” (D'Aveni, 2010a). Commoditisation is usually the failure of 
owners/managers to act early – they either fail to see the commodity trap looming or act in 
a timely manner to avoid it. Community pharmacy has been in the commodity trap for some 
years now. Pharmacies have seen their competitive position eroded and pricing power lost. 
Many pharmacy products and services have become indistinguishable from other 
competitors (which include supermarkets, department stores and service stations) with the 
result that customers buy on price alone. Typically, pharmacy managers fight the 
discounters by discounting their own products – this is never effective as it simply increases 
the depth and severity of the commodity trap. The discounters have the organisational slack 
to retaliate aggressively against which the average community pharmacy owner cannot 
hope to counter. Instead, traditional pharmacy owners need to try to build on and market 
their points of difference from the discounter. 
  
A traditional business management response to commoditisation would be to reduce costs, 
and increase efficiencies in workflow and processes. However, it is unlikely that these 
strategies will do little more than keep the wolf from the door and certainly will not create 
long-term sustainable competitive advantage. In fact, these strategies may make things 
worse trapping pharmacies in a never-ending cycle of hypercompetition. So, what to do to 
escape this commodity trap? To come up with a strategy to get out of this commodity trap, 
pharmacy owners and managers need to first understand how the trap came into being.  
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The deterioration of the pharmacy market came about with the entry of discount 
pharmacies with their low-cost/low-benefit offerings that appealed to the mass population. 
There was also erosion of the market through de-scheduling of many S2 medicines to open 
sellers with the result that many medicines are now sold in supermarkets, petrol stations 
and newsagencies. Consumers became even more price-conscious as the global financial 
crisis created uncertainty about Australia’s long-term economic outlook reducing 
discretionary spending and increasing personal savings as a consequence.  So, the question 
to ask here is, “How did the discount pharmacies’ customer value proposition become so 
superior to other pharmacies’ offerings in the eyes of pharmacy customers?”  Very easy – 
the majority of community pharmacies did not build on the point of difference nor market 
this difference as a value-add to consumers when the discounters first appeared in the 
pharmacy market. Many did not focus on providing superior customer service through 
patient counselling on prescription medicines, pharmacist consultations and medication 
management activities and hid (and continue to hide) pharmacists in the dispensary 
dispensing prescriptions when they should have them standing on the S2/S3 medicines 
counter providing customer advice on their health and medicines. Instead, customers are 
often served by pharmacy assistants who are either not trained, or if they are, not 
encouraged to ask the appropriate questions of customers when faced with either a 
product-based or symptoms-based request. Mystery shoppers continually report that the 
two questions pharmacy assistants usually ask when serving a customer for a product-based 
request are, “Have you taken this medicine before?” and “What size would you like?” 
despite the availability of the excellent What-Stop-Go protocol with its structured 
information-gathering process and the Pharmaceutical Society of Australia’s ‘Professional 
Practice Standards’. As a result, in the eyes of a consumer, the points of difference between 
the traditional pharmacy model and the discount/warehouse model are perhaps a nicer 
shopping experience, but slower service and more expensive products. It would appear that 
a growing number of pharmacy customers are choosing the discounters’ value proposition 
over that of traditional pharmacies and increasingly purchasing pharmacy goods from these 
pharmacies, either physically or online. Clearly, in order to survive, traditional pharmacies 
need a strategy or strategies to escape this commodity trap. 
 
Commoditisation is a complex problem and requires a multi-pronged approach to its 
solution. Part of the answer lies in making cost and capacity efficiencies, reducing 
discretionary spending wherever possible and changing workflow models putting 
pharmacists on the S2/S3 counter alongside pharmacy assistants. Improved customer 
service, increased levels of staff training, more effective pricing and reducing prescription 
wait times is also a step in the right direction. The next step which most traditional 
pharmacies have now embarked on is differentiation through the implementation of 
professional services. A focussed, differentiator strategy based on the implementation of 
professional services may provide these independent pharmacies with a viable option. The 
Guildcare suite of programmes developed by the Pharmacy Guild of Australia offers a 
framework for community pharmacies to commence the implementation of this strategy.  
However, it should be noted here that many of the discounters have already moved along 
the price-quality continuum and now also offer the GuildCare suite of professional 
programs. Therefore, to obtain true competitive advantage, pharmacies need to use the 
Guildcare suite as the foundation upon which to build, and preferably extend, a service 
model which delivers professional services of a consistent and sufficiently high quality to 
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achieve high patient satisfaction levels. Offering a suite of professional services in itself will 
not guarantee customer loyalty and repeat business – patient trust needs to be developed 
through sincerity and competence (Perepelkin and Di Zhang, 2011). Therefore to increase 
the potential for developing patient/customer loyalty to the pharmacy, pharmacists need to 
ensure that these services are delivered with a patient-centred focus rather than a dollar-
centred focus. This is not saying that profit is not important – it is. But if patients do not feel 
that the pharmacist delivering the service is truly empathetic then trust will not be 
forthcoming and they will seek another pharmacy offering the same service.  
 
Unfortunately, differentiation is only part of the solution to beat the deterioration 
commodity trap. If pharmacies choose to deliver these professional services in exactly the 
same way and to the same level of quality as their competitors (with no difference in 
offering apparent to the patient) then there is a real risk of community pharmacy falling into 
yet another commodity trap of their own making - the differentiation proliferation trap 
described by D’Aveni (D'Aveni, 2010b, D'Aveni, 2010a). Once an industry is caught in a 
commodity trap, D’Aveni (2010a) argues that differentiation is rarely enough to get it back 
out.  
 
Part of the reason for this second looming commodity trap (differentiation proliferation) is 
that in a hypercompetitive market competitive advantage is almost impossible to sustain 
over time due to the extremely fast retaliatory actions of competitors (D'Aveni, 1994). As 
stated above, the discounters have already moved into the delivery of professional services. 
Therefore, this differentiation strategy must be executed to a very high quality, and it needs 
to be innovative to stand out from the crowd. It also needs to be marketed well – customers 
need to be made aware of the pharmacy’s new value proposition with these professional 
services - because the window of opportunity is closing fast. With much higher margins 
through superior cost efficiencies, the cost leaders are in a stronger financial position and 
have already moved along the price-quality continuum to offer professional services. After 
all, the discounters have the margins to absorb the higher wages for the extra pharmacists 
required to deliver this superior level of service.   
 
If cost efficiencies and basic differentiation are still not sufficient to build the escape ladder 
out of the commodity trap what else can traditional community pharmacy owners and 
managers do? Well, apart from leaving the industry altogether, there are three options at 
this point. The first option is move out of the product market altogether and simply offer a 
purely service-oriented model. This is difficult with enormous sunk costs in inventory, 
fixtures and fittings. The second option is to move upscale away from the low-end of the 
market where the discounters are currently operating. Offer some very unique, rare service 
or product that the discounters cannot offer without a significant change to their business 
model. Further savings can be achieved through rationalising inventory, retaining only those 
categories that are profitable and which support the new market positioning of the 
pharmacy. Moving upscale requires superior market strategies and planning in order to sell 
this new value proposition to consumers to the extent that they are prepared to pay more 
for some of the unique benefits of your new offering. The third option again is all about 
marketing strategy and planning and involves redefining price. The key to the dominant 
pharmacy market share of the discounters is price and traditional pharmacies can 
undermine the discounters by changing the way pharmacy customers view price in relation 
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to pharmacy goods and services. This will require an effective marketing strategy, and 
creating a powerful brand image to which customers can develop an emotional attachment 
will not happen overnight. It requires tying product price in with service in some intrinsic 
way so that the customer doesn’t just focus on the initial product purchase price but is 
made aware of the comparative prices of two longer-term completely different health and 
wellness value propositions. If successfully executed, redefining price has the potential to 
effectively erode the leverage discount pharmacies obtain from their strategy of purely 
focussing on product price.  
 
The purpose of this article has been to highlight the characteristics of the pharmacy 
industry’s commodity trap and provide solutions on how to climb out of it. Today’s 
pharmacy customers are more confident, knowledgeable and better-informed than ever 
before – they are price-shopping and willing and able to use technology to reduce their 
pharmacy bills and save time. Other professions are also experiencing this change in 
consumer behaviour e.g. the legal profession (Mucalov, 2006). The legal profession has 
found that consumers are shopping on line for paralegal services and are even prepared to 
pay for cheaper legal services outsourced offshore. In light of this changing consumer 
behaviour pattern, the time for pharmacy to act is now. The traditional pharmacy model we 
knew and valued is fast disappearing. As the level of hypercompetition increases in the 
pharmacy industry, smaller traditional pharmacy owners will find it harder and harder to 
compete and remain financially viable unless they change the way they do business. 
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